A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
Public ClinicalTrials.gov record NCT02869438. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
Study identification
- NCT ID
- NCT02869438
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 233 participants
Conditions and interventions
Conditions
Interventions
- Benralizumab Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 8, 2016
- Primary completion
- Jul 31, 2018
- Completion
- Jul 31, 2018
- Last update posted
- Oct 28, 2019
2016 – 2018
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Scottsboro | Alabama | 35768 | — |
| Research Site | Gilbert | Arizona | 85234 | — |
| Research Site | Denver | Colorado | 80206 | — |
| Research Site | Miami | Florida | 33174 | — |
| Research Site | Tampa | Florida | 33607 | — |
| Research Site | Vero Beach | Florida | 32960 | — |
| Research Site | Winter Park | Florida | 32789 | — |
| Research Site | Fort Mitchell | Kentucky | 41017 | — |
| Research Site | Rochester | Minnesota | 55905 | — |
| Research Site | New Bern | North Carolina | 28562 | — |
| Research Site | Cincinnati | Ohio | 45231 | — |
| Research Site | Oklahoma City | Oklahoma | 73103 | — |
| Research Site | Medford | Oregon | 97504 | — |
| Research Site | Philadelphia | Pennsylvania | 19140 | — |
| Research Site | Lampasas | Texas | 76550 | — |
| Research Site | McKinney | Texas | 75069 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02869438, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02869438 live on ClinicalTrials.gov.